Role of miR-15/16 in CLL

Cell Death and Differentiation

Volumn 22, Issue 1, 2015, Pages 6-11

  Pekarsky, Y ^a   Croce, C M ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN15 MICRORNA, HUMAN; MIRN16 MICRORNA, HUMAN; ONCOPROTEIN; RNA;

ADULT; ANIMAL; BIOSYNTHESIS; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MULTIGENE FAMILY; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ADULT; ANIMALS; CHROMOSOME ABERRATIONS; DOWN-REGULATION; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICRORNAS; MULTIGENE FAMILY; ONCOGENE PROTEINS; RNA, NEOPLASM;

EID: 84937707307     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.87     Document Type: Review

References (49)

1. Sgambati M, Linet M, Devesa S. Chronic Lymphocytic Leukemia, Epidemiological, Familial, and Genetic Aspects. Chronic Lymphocytic Leukemias, Revised and Expanded, 2nd edn. In: Cheson B (ed). Marcel Dekker, Inc: New York, NY, USA, 2001; pp 33-62.
2. Bullrich F, Croce C. Molecular Biology of Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemias, Revised and Expanded, 2nd edn In: Cheson B (ed). Marcel Dekker, Inc: New York, NY, USA, 2001; pp 9-32.
3. Edelmann J, Holzmann K, Miller F, Winkler D, Buhler A, Zenz T et al. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 2012; 120: 4783-4794.
4. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910-1916.
5. Stilgenbauer S, Nickolenko J, Wilhelm J, Wolf S, Weitz S, Dohner K et al. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 1998; 16: 1891-1897.
6. Elnenaei MO, Hamoudi RA, Swansbury J, Gruszka-Westwood AM, Brito-Babapulle V, Matutes E et al. Delineation of the minimal region of loss at 13q14 in multiple myeloma. Genes Chromosomes Cancer 2003; 36: 99-106.
7. Dong JT, Boyd JC, Frierson HF Jr. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer. Prostate 2001; 49: 166-171.
8. Bullrich F, Fujii H, Calin G, Mabuchi H, Negrini M, Pekarsky Y et al. Characterization of the 13q14 tumor suppressor locus in CLL: Identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res 2001; 61: 6640-6648.
9. Migliazza A, Bosch F, Komatsu H, Cayanis E, Martinotti S, Toniato E et al. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood 2001; 97: 2098-2104.
10. Rondeau G, Moreau I, Bezieau S, Petit JL, Heilig R, Fernandez S et al. Comprehensive analysis of a large genomic sequence at the putative B-cell chronic lymphocytic leukaemia (B-CLL) tumour suppresser gene locus. Mutat Res 2001; 458: 55-70.
11. Mertens D, Wolf S, Schroeter P, Schaffner C, Dohner H, Stilgenbauer S et al. Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood 2002; 99: 4116-4121.
12. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-15529.
13. Pekarsky Y, Calin GA, Aqeilan R. Chronic lymphocytic leukemia: Molecular genetics and animal models. Curr Top Microbiol Immunol 2005; 294: 51-70.
14. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
15. Ambros V. MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing. Cell 2003; 113: 673-676.
16. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
17. Kozomara A, Griffiths-Jones S. miRBase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014; 42(Database issue): D68-D73.
18. Allegra D, Bilan V, Garding A, Dohner H, Stilgenbauer S, Kuchenbauer F et al. Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia. Leukemia 2014; 28: 98-107.
19. Sampath D, Liu C, Vasan K, Sulda M, Puduvalli VK, Wierda WG et al. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia. Blood 2012; 119: 1162-1172.
20. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793-1801.
21. Catovsky D. Definition and diagnosis of sporadic and familial chronic lymphocytic leukemia. Hematol Oncol Clin North Am 2004; 18: 783-794, vii.
22. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944-13949.
23. Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood 2003; 101: 1220-1235.
24. Grabow S, Waring P, Happo L, Cook M, Mason KD, Kelly PN et al. Pharmacological blockade of Bcl-2, Bcl-x(L) and Bcl-w by the BH3 mimetic ABT-737 has only minor impact on tumour development in p53-deficient mice. Cell Death Differ 2012; 19: 623-632.
25. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440-1443.
26. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 1984; 224: 1403-1406.
27. Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with In vitro and In vivo chemoresponses. Blood 1998; 91: 3379-3389.
28. Adachi M, Tefferi A, Greipp PR, Kipps TJ, Tsujimoto Y. Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia. J Exp Med 1990; 171: 559-564.
29. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 2008; 105: 5166-5171.
30. Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 2011; 305: 59-67.
31. Teshima K, Nara M, Watanabe A, Ito M, Ikeda S, Hatano Y et al. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma. Oncogene 2013; 33: 2191-2203.
32. Cai CK, Zhao GY, Tian LY, Liu L, Yan K, Ma YL et al. miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma. Oncol Rep 2012; 28: 1764-1770.
33. Jiang QQ, Liu B, Yuan T. MicroRNA-16 inhibits bladder cancer proliferation by targeting Cyclin D1. Asian Pac J Cancer Prev 2013; 14: 4127-4130.
34. Reid G, Pel ME, Kirschner MB, Cheng YY, Mugridge N, Weiss J et al. Restoring expression of miR-16: A novel approach to therapy for malignant pleural mesothelioma. Ann Oncol 2013; 24: 3128-3135.
35. Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek SN. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res 2008; 68: 1012-1021.
36. Hammarsund M, Corcoran MM, Wilson W, Zhu C, Einhorn S, Sangfelt O et al. Characterization of a novel B-CLL candidate gene-DLEU7-located in the 13q14 tumor suppressor locus. FEBS Lett 2004; 556: 75-80.
37. Palamarchuk A, Efanov A, Nazaryan N, Santanam U, Alder H, Rassenti L et al. 13q14 deletions in CLL involve cooperating tumor suppressors. Blood 115: 3916-3922.
38. Pekarsky Y, Zanesi N, Aqeilan RI, Croce CM. Animal models for chronic lymphocytic leukemia. J Cell Biochem 2007; 100: 1109-1118.
39. Haiat S, Billard C, Quiney C, Ajchenbaum-Cymbalista F, Kolb JP. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. Immunology 2006; 118: 281-292.
40. Mackay F, Schneider P, Rennert P, Browning J. BAFF AND APRIL: A tutorial on B cell survival. Annu Rev Immunol 2003; 21: 231-264.
41. Schuh K, Avots A, Tony HP, Serfling E, Kneitz C. Nuclear NF-ATp is a hallmark of unstimulated B cells from B-CLL patients. Leuk Lymphoma 1996; 23: 583-592.
42. Berland R, Wortis HH. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells. J Immunol 1998; 161: 277-285.
43. Katsumata M, Siegel RM, Louie DC, Miyashita T, Tsujimoto Y, Nowell PC et al. Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci USA 1992; 89: 11376-11380.
44. Lee SY, Reichlin A, Santana A, Sokol KA, Nussenzweig MC, Choi Y. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 1997; 7: 703-713.
45. Zapata JM, Krajewska M, Morse HC 3rd, Choi Y, Reed JC. TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice. Proc Natl Acad Sci USA 2004; 101: 16600-16605.
46. Raveche ES. Possible immunoregulatory role for CD5B cells. Clin Immunol Immunopathol 1990; 56: 135-150.
47. Raveche ES, Salerno E, Scaglione BJ, Manohar V, Abbasi F, Lin YC et al. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 2007; 109: 5079-5086.
48. Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010; 17: 28-40.
49. Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 2013; 19: 202-208.